1. Home
  2. APPN vs VCEL Comparison

APPN vs VCEL Comparison

Compare APPN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APPN
  • VCEL
  • Stock Information
  • Founded
  • APPN 1999
  • VCEL 1989
  • Country
  • APPN United States
  • VCEL United States
  • Employees
  • APPN N/A
  • VCEL N/A
  • Industry
  • APPN Computer Software: Prepackaged Software
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • APPN Technology
  • VCEL Health Care
  • Exchange
  • APPN Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • APPN 2.4B
  • VCEL 2.1B
  • IPO Year
  • APPN 2017
  • VCEL 1997
  • Fundamental
  • Price
  • APPN $31.00
  • VCEL $40.15
  • Analyst Decision
  • APPN Hold
  • VCEL Strong Buy
  • Analyst Count
  • APPN 8
  • VCEL 8
  • Target Price
  • APPN $35.50
  • VCEL $62.00
  • AVG Volume (30 Days)
  • APPN 619.6K
  • VCEL 430.8K
  • Earning Date
  • APPN 07-31-2025
  • VCEL 07-31-2025
  • Dividend Yield
  • APPN N/A
  • VCEL N/A
  • EPS Growth
  • APPN N/A
  • VCEL 521.85
  • EPS
  • APPN N/A
  • VCEL 0.05
  • Revenue
  • APPN $633,613,000.00
  • VCEL $238,541,000.00
  • Revenue This Year
  • APPN $12.74
  • VCEL $23.03
  • Revenue Next Year
  • APPN $10.07
  • VCEL $24.52
  • P/E Ratio
  • APPN N/A
  • VCEL $705.61
  • Revenue Growth
  • APPN 13.15
  • VCEL 14.80
  • 52 Week Low
  • APPN $24.00
  • VCEL $37.39
  • 52 Week High
  • APPN $43.33
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • APPN 52.54
  • VCEL 44.33
  • Support Level
  • APPN $27.35
  • VCEL $40.53
  • Resistance Level
  • APPN $30.80
  • VCEL $43.57
  • Average True Range (ATR)
  • APPN 1.11
  • VCEL 1.62
  • MACD
  • APPN 0.14
  • VCEL -0.16
  • Stochastic Oscillator
  • APPN 87.92
  • VCEL 28.65

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: